Radiology & Early Detection for Lung Cancer Screening

Using medical imaging to help with early detection of lung cancer is a partnership for success.

Lung cancer remains the leading cause of cancer deaths in America, claiming more lives each year than breast, prostate, and colon cancer combined. One of the greatest challenges with lung cancer is that it often develops silently and painlessly. By the time symptoms such as persistent cough, chest pain, or shortness of breath become noticeable, the disease may already be in an advanced stage. This is where the importance of early detection through lung cancer screening comes in, and where radiology plays a lifesaving role.

The most effective tool for early lung cancer screening detection is the low dose computed tomography (LDCT) scan. Unlike a standard chest x-ray, an LDCT provides detailed cross-sectional images of the lungs, allowing radiologists to detect even the smallest nodules or abnormalities. These high-resolution images make it possible to detect cancer at a much earlier stage, where treatment is more effective, and survival rates are significantly higher.

Radiology is not just about producing images; it’s about interpreting them with precision. Radiologists trained in lung cancer screenings can distinguish between findings that are suspicious and those that are benign, helping reduce unnecessary procedures while ensuring serious conditions are not overlooked. Advances in imaging protocols and artificial intelligence are also enhancing radiologists’ ability to detect subtle changes over time, offering patients an added layer of accuracy and safety.

Current recommendations from the U.S. Preventive Services Task Force (USPSTF) us for annual LDCT scans in adults aged 50 to 80 years with a 20-pack year or greater smoking history who either still smoke or have quit within the last 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops health conditions that substantially limit life expectancy¹. For these individuals, lung cancer screening is not just a diagnostic test; it’s a potential lifeline. Larger scale studies, including the National Lung Screening Trial (NLST) have demonstrated that LDCT screenings can reduce lung cancer mortality by as much as 20%².

The screening itself is quick, painless, and noninvasive. The scan takes just a few minutes, uses a very low dose of radiation (about the same as a mammogram), and requires no injections or special preparations. For many, the reassurance that comes with a clear scan is invaluable. If an abnormality is found, radiology provides a roadmap for next steps – whether that means follow-up imaging, a biopsy, or surgical planning.

Lung cancer screening represents an example of how radiology directly impacts patient outcomes. Rather than being reactive and diagnosing disease after symptoms appear, lung cancer screenings are proactive by identifying disease in its earliest and most treatable stages. In this way, radiology is not simply behind the scenes but at the forefront of saving lives.

If you or someone you love fits the screening criteria, talk to your healthcare provider about whether a low dose CT scan is right for you. Early detection can make all the difference. With the partnership of patients, providers, and radiologists, we can turn the tables against lung cancer, one scan at a time.

1US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10): 962

2National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine. 2011;365(5):395

By Ashley Kiernan, Lung Cancer Screening Navigator, Rutland Regional Medical Center